Testing the Long-Term Stability of Vancomycin Ophthalmic Solution

McLellan, Christine; Ngo, Van; Pasedis, Sophia; Dohlman, Claes H

Abstract

Testing the Long-Term Stability of Vancomycin Ophthalmic Solution

Author(s): McLellan Christine, Ngo Van, Pasedis Sophia, Dohlman Claes H

Issue: Sep/Oct 2008 - Veterinary Compounding

View All Articles in Issue

Page(s): 456-459

Download in electronic PDF format for $75

Abstract

Some patients with a keratoprosthesis (artificial cornea) are required to use prophylactic vancomycin ophthalmic solution daily for life to prevent infection, a regimen which has proven to be highly successful. The objective of this study was to determine whether such vancomycin solutions would remain stable at room temperature for an extended period of time, beyond that suggested by available published stability data and used in current practice. By relaxing the storage requirement and extending the expiration date of this solution, it was hoped that patient adherence and satisfaction would increase. The studied vancomycin ophthalmic solutions were compounded at the Massachusetts Eye and Ear Infirmary, Department of Pharmacy Services, Boston, Massachusetts, and were sent to an outside laboratory for high-performance liquid chromatography potency testing at predefined time points. Vancomycin 14-mg/mL ophthalmic solution compounded with 0.005% benzalkonium retains potency for at least 60 days at room temperatu

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Sep/Oct 2008 Pg. 456-459	Testing the Long-Term Stability of Vancomycin Ophthalmic Solution Author(s): McLellan Christine, Ngo Van, Pasedis Sophia, Dohlman Claes H
Jan/Feb 2003 Pg. 10-15 View Sample	Compounding for the Effects of Weapons of Mass Destruction Author(s): Sammarco Domenic A
Jul/Aug 2016 Pg. 347-350	Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product Author(s): Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
Sep/Oct 2010 Pg. 421	Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2001 Pg. 310-312	Wetting and/or Solubilizing Agents, Featured Excipient: Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 508	Vancomycin 31-mg/mL Ophthalmic Solution Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 56	Vancomycin 5% and Amikacin 2% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 336-341	Long-term Stability of Epitheliotropic Factors in Frozen Serum Eye Drops Author(s): Sahyoun Jean-Yves, Cloutier Marc, Frenette Mathieu, Robert Marie-Claude
Jul/Aug 2022 Pg. 330-335	Physicochemical and Microbiological Stability of Vancomycin 10-mg/mL Intravitreal Syringes Author(s): Bartoll Aaron Puplà, Bellés Medall Maria Dolores, Peñarrocha Josep Edo, Escrig Laura Solaz, Clemente Ruben Eguren, Azuara Julia Bodega, Piqueres Raul Ferrando
Sep/Oct 2016 Pg. 416-420	Long-term Stability of Vancomycin Hydrochloride in Glucose 5% Polyolefin Bags: The Brand Name Versus a Generic Product Author(s): Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
Jul/Aug 2010 Pg. 346-349	Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin Author(s): Baker Daniel S, Waldrop Bruce, Arnold John
Nov/Dec 2016 Pg. 495-500	Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 159-163	Stability of Commercially Available Grape and Compounded Cherry Oral Vancomycin Preparations Stored in Syringes and Cups Author(s): Kirk Loren, Lewis Paul, Luu Yao, Brown Stacy
Mar/Apr 1997 Pg. 123-124	Stability of Vancomycin HCl in MEDICATION CASSETTE Reservoirs Author(s): Allen Loyd V Jr, Stiles M Lou
Jan/Feb 2025 Pg. 51	Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution Author(s):
Sep/Oct 2016 Pg. 399-404	Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions Author(s): Allen Loyd V Jr
Mar/Apr 2008 Pg. 170-173	Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration Author(s): Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A
Jan/Feb 2002 Pg. 55-57	New Perspectives on Vancomycin Use in Home Care, Part 2: Delivery Systems Author(s): Kastango Eric S, Hadaway Lynn
Mar/Apr 2004 Pg. 156-159	Effect of Freezing, Long-Term Storage and Microwave Thawing on the Stability of Tramadol in 5% Dextrose Infusion in Polyvinyl Chloride Bags Author(s): Lebrun John, Hecq Jean-Daniel, Vanbeckbergen Danielle, Jamart Jacques, Galanti Laurence M
Sep/Oct 2017 Pg. 417	Vancomycin 50 mg/mL in Oral Syrup Suspension Author(s): Allen Loyd V Jr